These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16164632)

  • 1. Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.
    Cohen MP; Chen S; Ziyadeh FN; Shea E; Hud EA; Lautenslager GT; Shearman CW
    Kidney Int; 2005 Oct; 68(4):1554-61. PubMed ID: 16164632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.
    Cohen MP; Ziyadeh FN; Hong SW; Shearman CW; Hud E; Lautenslager GT; Iglesias-de la Cruz MC; Chen S
    Kidney Int; 2002 Jun; 61(6):2025-32. PubMed ID: 12028443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
    Cohen MP; Lautenslager GT; Hud E; Shea E; Wang A; Chen S; Shearman CW
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F789-95. PubMed ID: 17018845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalizing glycated albumin reduces increased urinary collagen IV and prevents renal insufficiency in diabetic db/db mice.
    Cohen MP; Hud E; Shea E; Shearman CW
    Metabolism; 2002 Jul; 51(7):901-5. PubMed ID: 12077739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy.
    Cohen MP; Sharma K; Jin Y; Hud E; Wu VY; Tomaszewski J; Ziyadeh FN
    J Clin Invest; 1995 May; 95(5):2338-45. PubMed ID: 7738197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting albumin glycation ameliorates diabetic nephropathy in the db/db mouse.
    Cohen MP; Masson N; Hud E; Ziyadeh F; Han DC; Clements RS
    Exp Nephrol; 2000; 8(3):135-43. PubMed ID: 10810230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells.
    Chen S; Cohen MP; Lautenslager GT; Shearman CW; Ziyadeh FN
    Kidney Int; 2001 Feb; 59(2):673-81. PubMed ID: 11168949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
    Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albumin.
    Cohen MP; Hud E; Wu VY
    Kidney Int; 1994 Jun; 45(6):1673-9. PubMed ID: 7933815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections.
    Chen S; Cohen MP; Ziyadeh FN
    Kidney Int Suppl; 2000 Sep; 77():S40-4. PubMed ID: 10997689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
    Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
    Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ethyl Acetate Extract of
    Lin CH; Shih CC
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M; Park JK; Overheu D; Kirsch T; Lindschau C; Gueler F; Leitges M; Menne J; Haller H
    Diabetes; 2007 Feb; 56(2):346-54. PubMed ID: 17259378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system.
    Ziyadeh FN; Han DC; Cohen JA; Guo J; Cohen MP
    Kidney Int; 1998 Mar; 53(3):631-8. PubMed ID: 9507208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
    Cohen MP; Ziyadeh FN
    J Am Soc Nephrol; 1996 Feb; 7(2):183-90. PubMed ID: 8785386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K; Maeshima Y; Yamamoto Y; Kitayama H; Takazawa Y; Hirokoshi K; Sugiyama H; Yamasaki Y; Eguchi K; Makino H
    Diabetes; 2005 Oct; 54(10):2891-903. PubMed ID: 16186390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
    Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
    Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.